|
|
||||||||
From the Laboratorio di Neurogenetica (Drs. Orlacchio and Bernardi), I.R.C.C.S. Santa Lucia, Rome; Dipartimento di Neuroscienze (Drs. Orlacchio and Bernardi), Università di Roma "Tor Vergata," Ospedale S. EugenioNeurologia, Rome, Italy; Centre for Research in Neurodegenerative Diseases (Drs. Orlacchio, Kawarai, Rogaeva, Song, and St. George-Hyslop), Tanz Neuroscience Building, University of Toronto; Program in Genetics and Genetic Biology (A.D. Paterson), The Hospital for Sick Children, Toronto; and Department of Medicine (Dr. St. George-Hyslop), Division of Neurology, University Health Network, Toronto, Ontario, Canada.
Address correspondence and reprint requests to Dr. A. Orlacchio, Laboratorio di Neurogenetica, I.R.C.C.S. Santa Lucia, Via Ardeatina 354, Rome 00179, Italy; e-mail: a.orlacchio{at}hsantalucia.it
Background: Seven loci for autosomal dominant hereditary spastic paraplegia (ADHSP) have been mapped. To date, two families of SPG12 (chromosome 19q13) have been analyzed; however, there is not enough clinical information on SPG12 to establish locus-phenotype correlations.
Methods: The authors studied 60 individuals from a large Italian family with ADHSP, in which 16 members in four generations were affected. They performed genetic linkage analysis with DNA markers from currently known ADHSP loci. After database searching, one candidate gene for SPG12 was analyzed by sequencing.
Results: The patients in this family showed an early onset and rapid progression of symptoms, resulting in severe disability, with a large proportion of affected members requiring use of a wheelchair. By age 16, most patients had sensory disturbance. Evidence for linkage to the SPG12 locus was obtained. Obligate recombination events observed in this family have narrowed the SPG12 locus from the 16.1 cM to 11.3 cM region between markers D19S416 and D19S412. In combination with previous genetic studies, the SPG12 locus was further narrowed to the 3.3 cM region between D19S416 and D19S220. A homologue of the AAA (ATPases associated with a variety of cellular activities) protein family, proteasome 26S subunit ATPase mapped near D19S220, was excluded by sequencing.
Conclusions: This study refined the SPG12 region between D19S416 and D19S220 and revealed several clinical characteristicsearly onset, rapid progression, and involvement of sensory disturbancethat may be unique to SPG12. Suggestive evidence of genetic anticipation was obtained, but should be confirmed in other SPG12 families.
This article has been cited by other articles:
![]() |
A. Orlacchio, C. Patrono, F. Gaudiello, C. Rocchi, V. Moschella, R. Floris, G. Bernardi, and T. Kawarai Silver syndrome variant of hereditary spastic paraplegia: A locus to 4p and allelism with SPG4 Neurology, May 20, 2008; 70(21): 1959 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Orlacchio, C Patrono, A Borreca, C Babalini, G Bernardi, and T Kawarai Spastic paraplegia in Romania: high prevalence of SPG4 mutations J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 606 - 607. [Full Text] [PDF] |
||||
![]() |
O. Lazarov, G. A. Morfini, G. Pigino, A. Gadadhar, X. Chen, J. Robinson, H. Ho, S. T. Brady, and S. S. Sisodia Impairments in Fast Axonal Transport and Motor Neuron Deficits in Transgenic Mice Expressing Familial Alzheimer's Disease-Linked Mutant Presenilin 1 J. Neurosci., June 27, 2007; 27(26): 7011 - 7020. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orlacchio, T. Kawarai, A. Totaro, A. Errico, P. H. St George-Hyslop, E. I. Rugarli, and G. Bernardi Hereditary Spastic Paraplegia: Clinical Genetic Study of 15 Families Arch Neurol, June 1, 2004; 61(6): 849 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orlacchio, F. Gaudiello, A. Totaro, R. Floris, P. H. St George-Hyslop, G. Bernardi, and T. Kawarai A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts Neurology, May 25, 2004; 62(10): 1875 - 1878. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |